000			01982 a2200577 4500
005			20250515184420.0
264		0	_c20090922
008			200909s 0 0 eng d
022			_a1179-1926
024	7		_a10.2165/11317190-000000000-00000 _2doi
040			_aNLM _beng _cNLM
100	1		_aPérez-Ruixo, Juan José
245	0	0	_aPharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects. _h[electronic resource]
260			_bClinical pharmacokinetics _c2009
300			_a601-13 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnemia _xdrug therapy
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aComputer Simulation
650	0	4	_aDrug Dosage Calculations
650	0	4	_aErythrocyte Count
650	0	4	_aErythropoietin
650	0	4	_aHalf-Life
650	0	4	_aHemoglobins _xanalysis
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Heavy Chains
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aModels, Biological
650	0	4	_aPeptides, Cyclic
650	0	4	_aReceptors, Erythropoietin _xagonists
650	0	4	_aRecombinant Fusion Proteins _xpharmacokinetics
650	0	4	_aReticulocyte Count
650	0	4	_aReticulocytes _xdrug effects
650	0	4	_aSingle-Blind Method
650	0	4	_aYoung Adult
700	1		_aKrzyzanski, Wojciech
700	1		_aBouman-Thio, Esther
700	1		_aMiller, Bruce
700	1		_aJang, Haishan
700	1		_aBai, Stephen A
700	1		_aZhou, Honghui
700	1		_aYohrling, Jennifer
700	1		_aCohen, Adam
700	1		_aBurggraaf, Jacobus
700	1		_aFranson, Kari
700	1		_aDavis, Hugh M
773	0		_tClinical pharmacokinetics _gvol. 48 _gno. 9 _gp. 601-13
856	4	0	_uhttps://doi.org/10.2165/11317190-000000000-00000 _zAvailable from publisher's website
999			_c19126206 _d19126206